New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial Gallery New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment, SanaCurrents Updates New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial By Bill Langbein|2020-07-06T10:23:39-04:00June 26th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment, SanaCurrents Updates|Tags: MGTA| Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...] Read More 0
